In-vitro Fertilization (IVF) Services Market is Expected to Reach $11.3 Billion, Globally, by 2021

In-vitro Fertilization (IVF) Services Report, published by Allied Market Research, forecasts that the global market is expected to garner market to reach $11.3 billion by 2021.United Stateswould continue to lead the market through 2021 and would have 321.7 thousand IVF cycles performed in 2021. Globally,Indiais projected to register highest growth both in terms of number of cycles and revenue.

The key factors that influence the growth of IVF cycles include, delayed pregnancy; a factor that is increasingly gaining prominence in developed economies, rise in infertility rates and increase in healthcare expenditures. Moreover, growing acceptance of the 3-parent IVF technique further contributing to the market growth. These factors would facilitate the number of cycles performed to reach 3,122.2 thousands by 2021, globally. On contrary, stringent regulations, limited success ratio and high costs of treatment would limit the market growth. Active initiatives by government, such as IVF refund programs, donor egg IVF programs, development of cost-effective IVF techniques and increasing popularity of fertility tourism would spur the market growth.

Geographically,the United States,China, andIndia, collectively holds about 42% of the market (IVF cycles) share due to increased rate of infertility and practices of embryo banking cycles, rising fertility tourism, and delayed parenthood decisions. On the other hand,Turkey,Israel,Brazil,Mexicowould emerge as key fertility tourism destinations during the forecast period mainly due to favorable government regulations and economic availability of skilled workforce and hospitality services.

Key Findings of In-vitro Fertilization (IVF) Services Market:

• In India, fertility clinics and hospitals segment collectively accounted for about 4/5th of the revenue generated in 2014
• Middle East accounted for about 65% revenue share of the LAMEA IVF market
• The Asia-Pacific IVF market is expected to grow at a promising CAGR of 8.9% from 2015 to 2021 in terms of volume
• China leads the Asia Pacific IVF market with about 44% volume share

Key players profiled in this report included Fertility and Gynecology Center, Monterey Bay IVF, Conceptions Reproductive Associates, Toronto Center for Advanced reproductive Technology Ltd., Liv Fertility Center inPuerto Vallarta, Klinikum Stuttgart, Heidelberg University Hospital, Clinique de la Muette, The Bridge Center,Sun Pharmaceuticals, Cadila Healthcare Ltd., LG Lifesciences, Vitrolife AB., EMD Serono, Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Clinica Anglo Americana, Cyprus IVF Center Lifesure Fertility & Gynecology Center and others.